|
Re: Timing is everything !!!
|
8
|
Resverlogix Corp.
|
Feb 25, 2016 10:26AM
|
|
Re: Apabetalone’s Positive Impact on COVID-19 in Human Lung Cells Published in Biomedicines
|
8
|
Resverlogix Corp.
|
Apr 21, 2021 10:47AM
|
|
Alpine Immune buyout by Vertex
|
8
|
Zenith Epigenetics
|
Apr 11, 2024 11:09AM
|
|
Re: Resverlogix Announces Two New Publications on Apabetalone in Kidney Disease
|
8
|
Resverlogix Corp.
|
Mar 28, 2018 08:00AM
|
|
Re: Lilly to Discontinue Development of Evacetrapib
|
8
|
Resverlogix Corp.
|
Oct 12, 2015 08:12PM
|
|
Re: you won’t see anyone buying this
|
8
|
Zenith Epigenetics
|
Dec 12, 2023 08:57AM
|
|
Re: Deja Vu All Over Again
|
8
|
Resverlogix Corp.
|
Mar 13, 2022 10:25AM
|
|
Re: “We will see how close we got”.....
|
9
|
Resverlogix Corp.
|
Nov 17, 2019 10:06AM
|
|
Re: Pfizer lays out ambitious vision for cancer portfolio in bid to reinvigorate its business.
|
9
|
Zenith Epigenetics
|
Mar 02, 2024 08:33AM
|
|
Re: MERK
|
9
|
Resverlogix Corp.
|
Sep 30, 2021 10:42AM
|
|
Re: Why investing in RVX is hard right now.....
|
9
|
Resverlogix Corp.
|
Jun 18, 2015 09:15AM
|
|
Re: Rought Transcript: RVX Presentation at GCFF Virtual Conference – Investing In Innovation – 09/10/2020
|
9
|
Resverlogix Corp.
|
Sep 18, 2020 08:43AM
|
|
Re: Revised target market, indications, market potential? ... and some numbers?
|
9
|
Resverlogix Corp.
|
Jun 13, 2020 12:06PM
|
|
Re: Just so...
|
9
|
Resverlogix Corp.
|
Oct 25, 2021 01:42PM
|
|
Re: RVX Current Status
|
10
|
Resverlogix Corp.
|
Feb 27, 2020 02:07PM
|
|
Re: Thinking back on an older discussion and wishing we had an update - Few items
|
10
|
Resverlogix Corp.
|
Jul 26, 2020 08:11PM
|
|
Re: Deja Vu All Over Again
|
10
|
Resverlogix Corp.
|
Mar 13, 2022 09:16AM
|
|
Re: Award of deferred shares and restricted shares
|
13
|
Resverlogix Corp.
|
Dec 21, 2020 11:37AM
|
|
Re: RVX Board Thoughts Mar 18 2022 – Wishful Thinking
|
13
|
Resverlogix Corp.
|
Mar 19, 2022 01:31PM
|
